Efficacy and Safety of Rucaparib in Patients With BRCA-Mutated Relapsed Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
British Journal of Cancer
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy and safety of rucaparib treatment in patients with BRCA-mutated, relapsed ovarian cancer: final results from Study 10
Br. J. Cancer 2022 Dec 08;[EPub Ahead of Print], RS Kristeleit, Y Drew, AM Oza, SM Domchek, S Banerjee, RM Glasspool, J Balmaña, LM Chen, MR Patel, HA Burris, T Safra, J Borrow, KK Lin, S Goble, L Maloney, R Shapira-FrommerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.